Comparing of the Pharmacokinetic, Safety and Immunogenicity of HS-20090-2 Injection and Prolia® in Healthy Adults
Clinical trial NCT04940845 · UNKNOWN
Trial details
- NCT number
- NCT04940845
- Sponsor
- Shanghai Hansoh Biomedical Co., Ltd
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-26
- Primary completion
- 2022-06-01
- Enrollment
- 174
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.